Adaptive Biotechnologies: Q4 Earnings Insights

Adaptive Biotechnologies ADPT reported its Q4 earnings results on Wednesday, February 14, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Adaptive Biotechnologies reported in-line EPS of $-0.3 versus an estimate of $-0.3.

Revenue was down $9.41 million from the same period last year.

Last quarter the company missed on EPS by $0.01 which was followed by a 18.18% drop in the share price the next day.

Here's a look at Adaptive Biotechnologies's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.34	-0.33	-0.38	-0.35
EPS Actual	-0.35	-0.33	-0.40	-0.28
Revenue Estimate	42.96M	45.48M	36.81M	55.27M
Revenue Actual	37.92M	48.93M	37.65M	55.20M

To track all earnings releases for Adaptive Biotechnologies visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar